Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

577nm Micropulse Laser vs Half-dose Photodynamic Therapy on Acute Central Serous Chorioretinopathy

NCT02587767
completedphase_2

Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy

NCT02735213
completednot_applicable

577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema

NCT02406157
completednot_applicable

Treatment Trial for Acute Central Serous Chorioretinopathy

NCT02784665

Clinical Trials (4)

Showing 4 of 4 trials
NCT02587767Not Applicable

577nm Micropulse Laser vs Half-dose Photodynamic Therapy on Acute Central Serous Chorioretinopathy

Completed
NCT02735213Phase 2

Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy

Completed
NCT02406157Not Applicable

577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema

Completed
NCT02784665Not Applicable

Treatment Trial for Acute Central Serous Chorioretinopathy

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4